Skip to Main Content

Paper Details

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.
Sci Rep
2
2023
ACVR1, ACVR1 mutation, ACVR1 mutations, DMG, Diffuse midline gliomas, EGFR, EZHIP, H3, H3-WT, H3-WT tumours, H3K27, H3K27M, H3K27M DMG, H3K27M mutation, H3K27me3, Histone, Histone H3, Patients, RNA, homeobox genes, midline gliomas, paediatric, paediatric tumours, patients, tumours, wild-type H3K27M
Author NameAffiliation
Chelsea MayohLowy Cancer Research Centre, Children's Cancer Institute
Chelsea MayohSchool of Clinical Medicine
Chelsea MayohUniversity of New South Wales Centre for Childhood Cancer Research
Mark J CowleyLowy Cancer Research Centre, Children's Cancer Institute
Mark J CowleySchool of Clinical Medicine
Mark J CowleyUniversity of New South Wales Centre for Childhood Cancer Research
Vanessa TyrrellLowy Cancer Research Centre, Children's Cancer Institute
Vanessa TyrrellSchool of Clinical Medicine
Vanessa TyrrellLowy Cancer Research Centre, Children's Cancer Institute
Vanessa TyrrellSchool of Clinical Medicine
Michelle HaberLowy Cancer Research Centre, Children's Cancer Institute
Michelle HaberSchool of Clinical Medicine
Michelle HaberUniversity of New South Wales Centre for Childhood Cancer Research
Paul G EkertLowy Cancer Research Centre, Children's Cancer Institute
Paul G EkertSchool of Clinical Medicine
Paul G EkertUniversity of New South Wales Centre for Childhood Cancer Research
Paul G EkertPeter MacCallum Cancer Centre
Paul G EkertUniversity of Melbourne
David S ZieglerLowy Cancer Research Centre, Children's Cancer Institute
David S ZieglerSchool of Clinical Medicine
David S ZieglerUniversity of New South Wales Centre for Childhood Cancer Research
David S ZieglerKids Cancer Centre, Sydney Children's Hospital
  • 1 - 22

Datasets

Release 1.2